Nitnib 12.5 mg Capsule (Zydus): High-Precision Oncology Sourcing for Global Medical Institutions
Are you searching for a reliable Nitinib 12.5 mg capsule exporter from India? Ernest Impex, a key member of the Group of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of targeted anti-cancer medications. We manage a secure, cold-chain-compliant supply network serving Washington (USA), London (UK), Bangkok (Thailand), Canberra (Australia), Singapore, and Kingston (Jamaica), ensuring that Zydus oncology products reach global distributors with 100% pharmaceutical integrity.
Detailed Product Overview: What is Nitnib 12.5 mg?
Nitnib 12.5 mg Capsule is an oral multi-targeted tyrosine kinase inhibitor (TKI) containing Sunitinib. Manufactured by Zydus Cadila, a global pharmaceutical giant, the 12.5 mg strength is a critical titration dose. It is primarily used to tailor treatment regimens, allowing oncologists to adjust the dose based on patient tolerability and clinical response.
For international B2B procurement, Nitnib 12.5 mg is an essential component in managing metastatic cancers, where precise dosage is vital to balance efficacy and safety.
Primary Therapeutic Indications
Nitnib 12.5 mg is clinically utilized globally for the following:
Gastrointestinal Stromal Tumor (GIST): For patients whose disease has progressed or who are intolerant to previous therapies like Imatinib.
Advanced Renal Cell Carcinoma (mRCC): An established first-line and second-line treatment for advanced-stage kidney cancer.
Pancreatic Neuroendocrine Tumors (pNET): For progressive, well-differentiated tumors where surgery is not an option.
Mechanism of Action: Multi-Receptor Pathway Suppression
Nitnib 12.5 mg works by disrupting the specific biological pathways that tumors use to grow and spread:
VEGF Receptor Blockade: Sunitinib inhibits all receptors for vascular endothelial growth factors (VEGFR-1, -2, and -3). This triggers anti-angiogenesis, effectively cutting off the tumor's blood supply.
PDGF Receptor Targeting: By inhibiting Platelet-Derived Growth Factor Receptors (PDGFR-Ξ± and -Ξ²), it prevents the structural support the tumor needs to expand.
KIT and FLT3 Inhibition: It targets specific proteins (KIT and FLT3) responsible for the rapid, uncontrolled division of cancer cells in the gastrointestinal tract and blood.
Dual-Impact Suppression: This combination of "starving" the tumor of nutrients while simultaneously halting cell division makes Nitnib a potent weapon against metastatic disease.
Administration and Clinical Safety
Dosage Protocol: Typically taken once daily. In many GIST/RCC cases, it is administered on a 6-week cycle (4 weeks on treatment, followed by a 2-week break).
Storage: Store at room temperature (below 30Β°C). Keep the capsules in their original container to protect from light and moisture.
Key Monitoring Parameters:
Hypertension: Blood pressure must be monitored frequently as Sunitinib can cause significant spikes.
Thyroid Function: Routine screening for hypothyroidism is standard practice during treatment.
Blood Glucose: Diabetic patients must monitor levels closely as Nitnib can cause hypoglycemia.
Liver & Heart Health: Periodic liver function tests (LFTs) and cardiovascular assessments are recommended.
Why Source Nitnib 12.5 mg from Ernest Impex?
Authentic Zydus Cadila Exporter: Direct access to genuine Zydus inventory ensures 100% authenticity and highly competitive wholesale pricing for global markets.
Specialized Logistics Authority: We are experts in the complex documentation and specialized cold-chain logistics required for Washington, London, Bangkok, Canberra, Singapore, and Kingston.
Regulatory Transparency: We provide all essential B2B documentation, including GMP compliance, batch-specific Certificates of Analysis (COA), and international export permits.
Supply Chain Resilience: In 2026, we prioritize digital traceability and consistent bulk fulfillment for hospital groups and regional distributors.
π Contact Ernest Impex β Pharmaceutical Exporter from India
[GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.]
π Websites:
π§ Email:
π¦ Business Type: Exporter | Bulk Supplier | Distributor
π² WhatsApp: +91 93599 02383
